|
Monday, March 3, 2025 |
|
華領醫藥榮獲上海市創新型企業總部授牌 |
2月27日,第二批上海市創新型企業總部授牌儀式在滬舉行,上海市市委副書記、市長龔正為49家創新型企業總部授牌,華領醫藥榮列其中。公司創始人、首席執行官陳力博士上台接受授牌,並作為企業代表進行發言。 more info >> |
|
华领医药荣获上海市创新型企业总部授牌 |
2月27日,第二批上海市创新型企业总部授牌仪式在沪举行,上海市市委副书记、市长龚正为49家创新型企业总部授牌,华领医药荣列其中。公司创始人、首席执行官陈力博士上台接受授牌,并作为企业代表进行发言。 more info >> |
|
Saturday, November 30, 2024 |
|
Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate |
Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China BioMed Innovation and Investment Conference (CBIIC). more info >> |
|
華領醫藥宣佈成功完成在美國開展的第二代葡萄糖激酶激活劑I期臨床研究 |
more info >> |
|
华领医药宣布成功完成在美国开展的第二代葡萄糖激酶激活剂I期临床研究 |
华领医药(“公司”,香港联交所股份代号:2552.HK)今天在第九届中国医药创新与投资大会(The China BioMed Innovation and Investment Conference,以下简称CBIIC)上宣布,已经成功完成在美国开展的第二代葡萄糖激酶激活剂(GKA)的Ia临床研究。 more info >> |
|
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC |
Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin improves the β-cell glucose sensitivity at the 9th China BioMed Innovation and Investment Conference (CBIIC). more info >> |
|
華領醫藥宣佈成功完成在中國香港開展的SENSITIZE研究 |
華領醫藥(「公司」,香港聯交所股份代號:2552.HK)今天在第九屆中國醫藥創新與投資大會(The China BioMed Innovation and Investment Conference,以下簡稱CBIIC)上宣佈,公司已經成功完成與香港中文大學Juliana Chan教授團隊合作開展SENSITIZE研究,該研究為多格列艾汀改善β細胞葡萄糖敏感性的作用機制研究。 more info >> |
|
华领医药宣布成功完成在中国香港开展的SENSITIZE研究 |
华领医药(“公司”,香港联交所股份代号:2552.HK)今天在第九届中国医药创新与投资大会(The China BioMed Innovation and Investment Conference,以下简称CBIIC)上宣布,公司已经成功完成与香港中文大学Juliana Chan教授团队合作开展SENSITIZE研究,该研究为多格列艾汀改善β细胞葡萄糖敏感性的作用机制研究。 more info >> |
|
Friday, October 25, 2024 |
|
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award' |
The 17th C.C. Tan Life Science Award ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive Officer of Hua Medicine, was awarded the C.C. Tan Life Science Industrialization Award . more info >> |
|
Friday, August 30, 2024 |
|
Hua Medicine Announces 2024 Interim Results |
Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2024 (the "Reporting Period"), and the Company's business progress for the first half of the year and business outlook. more info >> |
|
|
|